Trial Profile
Open, Non-randomized Trial to Assess the Immunogenicity and Safety of the 2012/2013-Season Influenza Vaccine in Elderly and Young Subjects According to EMA Regulations
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine liposomal (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Crucell
- 01 Aug 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jul 2012 New trial record